Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Feb 28;3(3):231–238. doi: 10.1016/j.bpsc.2017.02.005

Table 1.

Demographics and clinical characteristicsa

Experiment 1 Experiment 2
FEP (n=23) HV (n=23) t/X2 p value HV (n=19) t/X2 p value
Gender (% male) 69.6% 69.6% 0.00 1.0 63.2%
Age 22.65 (1.03) 22.65 (0.93) 0.00 1.0 23.84 (3.67)
Parental Occupationb 4.61 (4.62) 3.78 (3.23) −8.56 .48 3.05 (3.66)
RBANSc
 Total index 70.30 (16.11) 92.62 (11.8) 5.08 <.01 97.79 (15.82)
 Immediate memory 80.05 (16.95) 101.33 (14.20) 4.37 <.01 106.21 (16.45)
 Visuospatial 76.45 (17.13) 85.76 (15.32) 1.84 .07 89.47 (16.63)
 Language 78.45 (13.41) 98.81 (14.82) 4.60 <.01 103.47 (12.66)
 Attention span 72.90 (16.69) 94.62 (17.24) 4.10 <.01 101.58 (16.35)
 Delayed memory 72.90 (20.84) 93.19 (8.70) 4.03 <.01 91.32 (12.76)
BPRSd Baseline Ketaminee
 Total score 34.36 (11.91) 20.84 (0.83) 39.47 (6.97) 11.12 <.01
 Positive 5.18 (2.82) 3.00 (0.00) 6.41 (1.54) 9.11 <.01
 Negative 6.73 (2.96) 3.32 (0.48) 6.76 (2.51) 6.03 <.01
a

Mean (SD) unless indicated otherwise

b

Ranks determined from Diagnostic Interview for Genetic Studies (1 – 18 scale); higher rank (lower numerical value) corresponds to higher socioeconomic status

c

Repeatable Battery for the Assessment of Neuropsychological Status, FEP: n= 20; HC: n= 21

d

Brief Psychiatric Rating Scale (1 – 7 scale); positive (conceptual disorganization, hallucinatory behavior, and unusual thought content); negative (emotional withdrawal, motor retardation, and blunted affect), n= 22

e

n= 17